Search

Your search keyword '"Audrezet, Marie-Pierre"' showing total 131 results

Search Constraints

Start Over You searched for: Author "Audrezet, Marie-Pierre" Remove constraint Author: "Audrezet, Marie-Pierre"
131 results on '"Audrezet, Marie-Pierre"'

Search Results

1. Sex, Genotype, and Liver Volume Progression as Risk of Hospitalization Determinants in Autosomal Dominant Polycystic Liver Disease

3. #2613 Clinical spectrum and prognosis of the atypical polycystic kidney disease caused by monoallelic loss-of-function IFT140 variants

4. Sex, Genotype, and Liver Volume Progression as Risk of Hospitalization Determinants in Autosomal Dominant Polycystic Liver Disease

5. Monoallelic pathogenic ALG5 variants cause atypical polycystic kidney disease and interstitial fibrosis

7. Clinical spectrum, prognosis and estimated prevalence of DNAJB11-kidney disease

12. CFTR‐France, a national relational patient database for sharing genetic and phenotypic data associated with rare CFTR variants

13. Targeted next‐generation sequencing in a large series of fetuses with severe renal diseases

14. Polycystin-1 but not polycystin-2 deficiency causes upregulation of the mTOR pathway and can be synergistically targeted with rapamycin and metformin

20. GENOTYPE-PHENOTYPE CORRELATION IN A PEDIATRIC ADPKD COHORT

21. Novel diagnostic tool for prediction of variant spliceogenicity derived from a set of 395 combined in silico/in vitro studies: an international collaborative effort (vol 46, pg 7913, 2018)

24. Common CFTR haplotypes and susceptibility to chronic pancreatitis and congenital bilateral absence of the www.hgvs.org vas deferens

25. P1799GENOTYPE-PHENOTYPE CORRELATION IN A PEDIATRIC ADPKD COHORT

26. Novel diagnostic tool for prediction of variant spliceogenicity derived from a set of 395 combined in silico/in vitro studies: an international collaborative effort

29. Analysis of genomic CFTR DNA

32. Risk estimation of uniparental disomy of chromosome 14 or 15 in a fetus with a parent carrying a non‐homologous Robertsonian translocation. Should we still perform prenatal diagnosis?

33. Combined Consideration of Sex, Genotype, and Total Liver Volume Progression Determines the Risk of Hospitalization in an International Multicenter Cohort of Autosomal Dominant Polycystic Liver Disease

34. Novel diagnostic tool for prediction of variant spliceogenicity derived from a set of 395 combined in silico/in vitro studies: an international collaborative effort

35. Novel diagnostic tool for prediction of variant spliceogenicity derived from a set of 395 combined in silico/in vitro studies: an international collaborative effort (vol 46, pg 7913, 2018)

37. Novel diagnostic tool for prediction of variant spliceogenicity derived from a set of 395 combined in silico/in vitro studies: an international collaborative effort

38. Large phenotypic spectrum associated with two new deep intronic variants on the CFTR gene

39. The expanded French compassionate programme for elexacaftor–tezacaftor–ivacaftor use in people with cystic fibrosis without a F508del CFTRvariant: a real-world study

40. Neonatal screening for cystic fibrosis in Brittany, France: assessment of 10 years' experience and impact on prenatal diagnosis

42. Small-scale high-throughput sequencing–based identification of new therapeutic tools in cystic fibrosis

44. Polycystin-1 but not polycystin-2 deficiency causes upregulation of the mTOR pathway and can be synergistically targeted with rapamycin and metformin

45. Common CFTR haplotypes and susceptibility to chronic pancreatitis and congenital bilateral absence of the vas deferens

46. Common CFTR haplotypes and susceptibility to chronic pancreatitis and congenital bilateral absence of the vas deferens

48. Immunoreactive trypsin/DNA newborn screening for cystic fibrosis: should the R117H variant be included in CFTR mutation panels?

50. CFTR genotypes in patients with normal or borderline sweat chloride levels

Catalog

Books, media, physical & digital resources